FXYD3 and lung carcinoma: Bioinformatic analysis tools were determinant to evaluate the role of a high expression of KDM3A (lysine demethylase 3A) and DCLK1 (doublecortin-like kinase 1) and reduced expression FXYD3 in lung cancer.